variables: 815287
Data license: CC-BY
This data as json
id | name | unit | description | createdAt | updatedAt | code | coverage | timespan | datasetId | sourceId | shortUnit | display | columnOrder | originalMetadata | grapherConfigAdmin | shortName | catalogPath | dimensions | schemaVersion | processingLevel | processingLog | titlePublic | titleVariant | attributionShort | attribution | descriptionShort | descriptionFromProducer | descriptionKey | descriptionProcessing | licenses | license | grapherConfigETL | type | sort | dataChecksum | metadataChecksum |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
815287 | Statin use for primary prevention amongst elibible individuals | % | 2023-10-10 15:55:36 | 2024-07-08 17:24:04 | 2019-2019 | 6266 | % | { "unit": "%", "shortUnit": "%", "numDecimalPlaces": 1 } |
0 | statin_use_primary | grapher/statins/2023-10-05/lancet_2022/lancet_2022#statin_use_primary | 2 | minor | Proportion of eligible individuals self-reporting use of statins for the primary prevention of cardiovascular disease | Eligibility for statin therapy for primary prevention was defined among individuals with a history of diagnosed diabetes or a 10-year cardiovascular disease risk of at least 20%. | [] |
float | [] |
ecfd6018675aa95b66e8dfc2018895ca | fbdcd19cb67676858d4f95e45d5cc2f0 |